FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Source: globenewswire.com
📰 Precision Timed Release News
Precision Timed Release News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Precision Timed Release. Real-time updates on events, politics, business and more.
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently ...
Source: businessinsider.com
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board ...
KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and
Source: eagletribune.com
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
KANSAS CITY, Kan., April 30, 2024 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a...
Source: marketscreener.com
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into ...
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build
Source: eagletribune.com
CING Stock Price | Cingulate Inc. Stock Quote (U.S.: Nasdaq)
CING | Complete Cingulate Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Matthewn Brams Shanej Schaffer Craig Steven Gilgallon Raulr Silva Cingulate Inc Precision Timed Release
Source: marketwatch.com
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. CING, a biopharmaceutical company utilizing its proprietary Precision Timed Release™…
Source: biztoc.com
Cingulate Shares Fall to 52-Week Low After Reverse Split
By Josh Beckerman Shares of Cingulate, which is developing drugs using its Precision Timed Release technology, fell to a 52-week low after a 1-for-20 reverse...
Josh Beckerman Precision Timed Release Permanent Product Measure Article Normal Anti Depressants Healthcare Life Sciences
Source: marketwatch.com
Cingulate to Host CNS Key Opinion Leader Panel in New York
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations...
Source: globenewswire.com
Cingulate Inc. To Present at the LD Micro Main Event | The Kingston Whig Standard
Kansas City, Kansas--(Newsfile Corp. - September 21, 2023) - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its
Source: thewhig.com